Purchases and Sales Made in Q3 2023 in Verve Therapeutics, Inc. (VERV)
This table provides information about the institutional ownership of Verve Therapeutics, Inc. (VERV) during Q3 2023. The information is specifically focused on institutions that hold shares of Verve Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 30, 2023
Q3 2023
|
Sumitomo Mitsui Trust Holdings, Inc.
|
SELL
|
- |
-38.6K- 1.77% |
$441K - $804K
|
2.15M
$11.2M
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-45.8K- 13.4% |
$523K - $954K
|
296K
$1.55M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-61.5K- 23.04% |
$703K - $1.28M
|
206K
$1.07M
|
|
|
Nov 14, 2023
Q3 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-65.1K- 76.7% |
$744K - $1.36M
|
19.8K
$103K
|
|
|
Oct 21, 2024
Q3 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-77.1K- 74.12% |
$880K - $1.6M
|
26.9K
$140K
|
|
|
Nov 14, 2023
Q3 2023
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-184K- 18.81% |
$2.1M - $3.82M
|
793K
$4.14M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-268K- 56.6% |
$3.06M - $5.58M
|
206K
$1.07M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-459K- 65.92% |
$5.24M - $9.55M
|
237K
$1.24M
|
|
|
Nov 14, 2023
Q3 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-593K- 67.52% |
$6.78M - $12.4M
|
285K
$1.49M
|